Anuh Pharma opened higher at ₹81.60, compared with its previous close of ₹81.18. During today's session, the stock has traded between ₹78.10 and ₹82.78, with an average traded price of ₹80.46. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 2 years ago in Anuh Pharma is now worth
₹ 7,293.00
resulting in a loss of
₹ 2,707.00 (27.07%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.09 (+0.11%)
Day High
₹82.78
Day Low
₹78.10
Day Open
₹81.60
Prev Close
₹81.18
Volume
53,326
Value Traded
₹0.43 Cr
1W Return
-3.42%
1M Return
-14.33%
3M Return
3.15%
6M Return
1.91%
1Y Return
-1.17%
Market Cap (₹ Cr.)
815
PE Ratio
18.40
PB Ratio
2.31
Dividend Yield
1.85%
ROE
11.65%
ROCE
15.43%
Book Value (₹)
35.14
Face Value (₹)
5.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-3.42%
6 Week
-
1 Month
-14.33%
3 Month
3.15%
9 Month
3.34%
No data available.
Anuh Pharma board approves ₹75 crore loan to expand manufacturing capacity
Board approved a loan of up to ₹75 crore. Funds designated for purchasing manufacturing assets. Objective is to expand production capacity. Decision taken during October 13, 2026 meeting. Subject to finalization of terms and approvals.
TodayAnuh Pharma receives ₹9.93 lakh tax demand order for AY 2018-19
Anuh Pharma received a ₹9.93 lakh tax demand for AY 2018-19. The order cites disallowance of deductions claimed under the Income Tax Act. Company plans to appeal before the Commissioner of Income Tax. Management states no impact on financial operations or activities.
25 days agoAnuh Pharma expects consistent yearly growth of 15-20%
Anuh Pharma has indicated expectations of consistent yearly growth in the range of 15-20%, reflecting a positive business outlook. No additional financial metrics, quarterly results, or segment-level details were disclosed alongside this guidance.
1mo agoAnuh Pharma approves ₹1.50 dividend, reappoints directors at AGM
Anuh Pharma Limited concluded its 66th AGM on August 12, 2026, approving a ₹1.50 per share dividend and reappointing directors Bipin N. Shah and Arun L. Todarwal. The meeting also saw the approval of remuneration revisions for Joint Managing Directors Ritesh B. Shah and Vivek B. Shah, alongside the adoption of new MOA and AOA documents.
1mo agoAnuh Pharma net profit rises 37.6% in Q1FY27 on margin expansion
Anuh Pharma's Q1FY27 standalone results show a 37.6% increase in net profit to ₹1,142.49 lakh, fueled by EBITDA margin expansion to 9.47% from 7.34%. Revenue grew 3.9% to ₹19,381.04 lakh. Promoters withdrew share reclassification applications.
2mo agoAnuh Pharma schedules 66th AGM on August 12, 2026
Anuh Pharma Limited has scheduled its 66th Annual General Meeting for August 12, 2026, via video conferencing to adopt financial statements for FY26 and declare a final dividend. The record date for dividend entitlement is August 5, 2026, with the register of members closing from August 6 to August 12. Remote e-voting facilities are available from August 9, 2026, at 9:00 a.m. to August 11, 2026, at 5:00 p.m.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 2 years ago in Anuh Pharma is now worth
₹ 7,293.00
resulting in a loss of
₹ 2,707.00 (27.07%)
Note: Past profits do not guarantee future returns.
